

Lancing Device for Diabetes Testing Market Scope:
Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The global market for Lancing Devices for Diabetes Testing is projected to reach a value of $1.2 billion by 2025, with a growth rate of 5.2%. The increasing prevalence of diabetes, technological advancements in devices, and rising awareness about self-monitoring are driving market growth. Key players include Roche, Abbott, and BD. Request
◍ Medtronic
◍ Roche
◍ Owen Mumford
◍ Lifescan
◍ Ascensia
◍ Accu-Chek
◍ B. Braun Medical
◍ Terumo
◍ BIONIME
◍ Sinocare
◍ Lobeck Medical AG
◍ GMMC Group
The competitive landscape for Lancing Device for Diabetes Testing Market includes companies like Medtronic, Roche, Owen Mumford, Lifescan, Ascensia, Accu-Chek, B. Braun Medical, Terumo, BIONIME, Sinocare, Lobeck Medical AG, and GMMC Group. These companies produce innovative lancing devices that help to grow the market by providing accurate and comfortable blood glucose testing solutions.
- Medtronic: $30.12 billion
- Roche: $60.03 billion
- B. Braun Medical: $7.97 billion
Request Sample Report
By Application
◍ Home Care
◍ Hospital & Clinics
By Product
◍ Adjustable Lancing Device
◍ Non-adjustable Lancing Device
Request Sample Report